State Ledger
Company profile

Monte Rosa Therapeutics, Inc. CIK 1826457

Ticker
GLUE (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Boston, MA 02118
Fiscal year end
2025 (FY)
Market Data
Close
$10.54
Change
+$0.22
Change %
2.08%
Volume
66,733

GLUE · trading date Oct 12, 2026 · previous close $10.32 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$38.63M
Total assets
$448.66M
Total liabilities
$215.60M
Stockholders' equity
$233.06M
Cash & equivalents
$129.88M
Operating income
-$54.21M
Operating cash flow
-$22.80M
Capital expenditures
$4.70M

Fiscal year 2025, via 10-K filed 2026-03-17. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$27.50M
Free cash flow margin
—
Liabilities / assets
48.1%
Equity / assets
51.9%
CapEx / revenue
—
Operating cash flow / net income
0.59×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$38.63M $448.66M $215.60M $233.06M
2024 — -$72.70M $438.73M $215.80M $222.94M
2023 — -$135.35M $303.76M $124.51M $179.25M
2022 — -$108.50M $342.39M $70.98M $271.41M
2021 — -$73.96M $366.33M $18.81M $347.52M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-08
Financials filed via
Form 10-K
filed 2026-03-17

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Boston, MA 02118
321 HARRISON AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:35 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies